CP Cerulean Pharma Inc. Stock: price and management transactions · United States · SEC (Form 4)Follow the Cerulean Pharma Inc. stock price and the full insider trade history of the company, a listed equity based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). The latest transaction was filed on 12 February 2016 (Acquisition). Among the most active insiders: WALT DAVID R. The full history is accessible without an account.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 12 February 2016
All Executives29 Thresholds0 Prospectus0 Other0
Declarations 29 total
▲ Director · Executives · 10 Feb 2016
4,500 shares Common Stock SEC:0001209191-16-098014:0
Canonical exit: 10 May 2016 (T+90) ▲ Director · Executives · 11 Feb 2016
4,350 shares Common Stock SEC:0001209191-16-098014:1
Canonical exit: 11 May 2016 (T+90) ▲ Director · Executives · 8 Feb 2016
4,500 shares Common Stock SEC:0001209191-16-097270:0
Canonical exit: 8 May 2016 (T+90) ▲ Director · Executives · 9 Feb 2016
4,500 shares Common Stock SEC:0001209191-16-097270:1
Canonical exit: 9 May 2016 (T+90) ▲ Director · Executives · 5 Feb 2016
4,500 shares Common Stock SEC:0001209191-16-096365:1
Canonical exit: 5 May 2016 (T+90) ▲ Director · Executives · 4 Feb 2016
4,063 shares Common Stock SEC:0001209191-16-096365:0
Canonical exit: 4 May 2016 (T+90) ▲ Director · Executives · 2 Feb 2016
4,395 shares Common Stock SEC:0001209191-16-095726:0
Canonical exit: 2 May 2016 (T+90) ▲ Director · Executives · 3 Feb 2016
4,018 shares Common Stock SEC:0001209191-16-095726:1
Canonical exit: 3 May 2016 (T+90) ▲ Director · Executives · 29 Jan 2016
1,200 shares Common Stock SEC:0001209191-16-094706:0
Canonical exit: 28 Apr 2016 (T+90) ▲ Director · Executives · 1 Feb 2016
4,500 shares Common Stock SEC:0001209191-16-094706:1
Canonical exit: 1 May 2016 (T+90) ▲ Director · Executives · 27 Jan 2016
4,500 shares Common Stock SEC:0001209191-16-094149:0
Canonical exit: 26 Apr 2016 (T+90) ▲ Director · Executives · 28 Jan 2016
4,500 shares Common Stock SEC:0001209191-16-094149:1
Canonical exit: 27 Apr 2016 (T+90) ▲ Director · Executives · 25 Jan 2016
4,500 shares Common Stock SEC:0001209191-16-093783:0
Canonical exit: 24 Apr 2016 (T+90) ▲ Director · Executives · 26 Jan 2016
4,300 shares Common Stock SEC:0001209191-16-093783:1
Canonical exit: 25 Apr 2016 (T+90) ▲ Director · Executives · 21 Jan 2016
4,500 shares Common Stock SEC:0001209191-16-093420:0
Canonical exit: 20 Apr 2016 (T+90) ▲ Director · Executives · 22 Jan 2016
4,500 shares Common Stock SEC:0001209191-16-093420:1
Canonical exit: 21 Apr 2016 (T+90) ▲ Director · Executives · 19 Jan 2016
4,400 shares Common Stock SEC:0001209191-16-092885:0
Canonical exit: 18 Apr 2016 (T+90) ▲ Director · Executives · 20 Jan 2016
4,500 shares Common Stock SEC:0001209191-16-092885:1
Canonical exit: 19 Apr 2016 (T+90) ▲ Director · Executives · 14 Jan 2016
4,400 shares Common Stock SEC:0001209191-16-092049:0
Canonical exit: 13 Apr 2016 (T+90) ▲ Director · Executives · 15 Jan 2016
4,172 shares Common Stock SEC:0001209191-16-092049:1
Canonical exit: 14 Apr 2016 (T+90) ▲ Director · Executives · 12 Jan 2016
4,300 shares Common Stock SEC:0001209191-16-091409:0
Canonical exit: 11 Apr 2016 (T+90) ▲ Director · Executives · 13 Jan 2016
4,384 shares Common Stock SEC:0001209191-16-091409:1
Canonical exit: 12 Apr 2016 (T+90) ▲ Director · Executives · 8 Jan 2016
4,500 shares Common Stock SEC:0001209191-16-090953:0
Canonical exit: 7 Apr 2016 (T+90) ▲ Director · Executives · 11 Jan 2016
4,355 shares Common Stock SEC:0001209191-16-090953:1
Canonical exit: 10 Apr 2016 (T+90) ▲ Director · Executives · 6 Jan 2016
4,500 shares Common Stock SEC:0001209191-16-090585:0
Canonical exit: 5 Apr 2016 (T+90) 25 of 29 declarations
Load more (4 remaining) Acerca de Cerulean Pharma Inc. Cerulean Pharma Inc. es una empresa biofarmacéutica centrada en el desarrollo de tratamientos innovadores para el cáncer. Cotiza en NASDAQ bajo el ticker CRLN.